{
    "2018-08-09": [
        [
            {
                "time": "",
                "original_text": "复星医药(02196)胃癌晚期新药获临床试验注册审评受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "胃癌",
                        "晚期",
                        "新药",
                        "临床试验",
                        "注册审评",
                        "受理"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药：控股子公司一款抗癌新药获临床试验申请受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "抗癌新药",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "9只资源股基金 哪只最正宗？",
                "features": {
                    "keywords": [
                        "资源股",
                        "基金",
                        "正宗"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资源"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "渤海证券医药行业周报：牢牢把握业绩主线",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "医药行业",
                        "周报",
                        "业绩主线"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海、陕西、海南加快通过仿制药一致性评价药品挂网",
                "features": {
                    "keywords": [
                        "上海",
                        "陕西",
                        "海南",
                        "仿制药",
                        "一致性评价",
                        "药品挂网"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}